Advertisement
Screener

OCUGEN, INC. (OCGN) Stock-Based Compensation

2.8 / 5 stars · 68/120 Roast Me

OCUGEN, INC. Stock-Based Compensation

OCUGEN, INC. (OCGN) reported Stock-Based Compensation of $1.83 million for the 3-month period ending 2026-06-30, per its 10-Q filed 2026-08-06.

Financial Statements › Expense Statement › Operating Expenses

us-gaap:AllocatedShareBasedCompensationExpense · last filed 2026-08-06

  • OCUGEN, INC. share-based payment arrangement, expense for the quarter ending 2026-06-30 was $1.83M, a 0.65% decline year-over-year.
  • OCUGEN, INC. share-based payment arrangement, expense for the quarter ending 2026-03-31 was $3.40M, a 80.27% increase year-over-year.
  • OCUGEN, INC. share-based payment arrangement, expense for the quarter ending 2025-12-31 was $2.00M, a 6.72% increase year-over-year.
  • OCUGEN, INC. share-based payment arrangement, expense for the quarter ending 2025-09-30 was $1.98M, a 4.44% increase year-over-year.
  • OCUGEN, INC. share-based payment arrangement, expense for fiscal 2025 was $7.71M, a 3.77% increase from fiscal 2024.
  • OCUGEN, INC. share-based payment arrangement, expense for fiscal 2024 was $7.43M, a 19.42% decline from fiscal 2023.
  • OCUGEN, INC. share-based payment arrangement, expense for fiscal 2023 was $9.22M, a 12.56% decline from fiscal 2022.
  • OCUGEN, INC. share-based payment arrangement, expense for fiscal 2022 was $10.54M, a 51.49% increase from fiscal 2021.
Period endShare-based Payment Arrangement, Expense 3 monthShare-based Payment Arrangement, Expense 3 month as first filedShare-based Payment Arrangement, Expense 6 monthShare-based Payment Arrangement, Expense 6 month as first filedShare-based Payment Arrangement, Expense 9 monthShare-based Payment Arrangement, Expense 9 month as first filedShare-based Payment Arrangement, Expense 12 monthShare-based Payment Arrangement, Expense 12 month as first filed
2026-06-30$1.83M
10-Q · filed 2026-08-06
$5.23M
10-Q · filed 2026-08-06
$7.23M
derived: sum of 3 quarters · filed 2026-08-06
$9.21M
derived: sum of 4 quarters · filed 2026-08-06
2026-03-31$3.40M
10-Q · filed 2026-05-08
$5.40M
derived: sum of 2 quarters · filed 2026-05-08
$7.38M
derived: sum of 3 quarters · filed 2026-05-08
$9.22M
derived: sum of 4 quarters · filed 2026-08-06
2025-12-31$2.00M
derived: 10-K 12 month − 10-Q 9 month · filed 2026-03-04
$3.98M
derived: sum of 2 quarters · filed 2026-03-04
$5.82M
derived: sum of 3 quarters · filed 2026-08-06
$7.71M
10-K · filed 2026-03-04
2025-09-30$1.98M
10-Q · filed 2025-11-05
$3.82M
derived: sum of 2 quarters · filed 2026-08-06
$5.71M
10-Q · filed 2025-11-05
$7.58M
derived: sum of 4 quarters · filed 2026-08-06
2025-06-30$1.84M
10-Q · filed 2026-08-06
$3.73M
10-Q · filed 2026-08-06
$5.61M
derived: sum of 3 quarters · filed 2026-08-06
$7.50M
derived: sum of 4 quarters · filed 2026-08-06
2025-03-31$1.89M
10-Q · filed 2026-05-08
$3.76M
derived: sum of 2 quarters · filed 2026-05-08
$5.65M
derived: sum of 3 quarters · filed 2026-05-08
$7.55M
derived: sum of 4 quarters · filed 2026-05-08
2024-12-31$1.88M
derived: 10-K 12 month − 10-Q 9 month · filed 2026-03-04
$3.77M
derived: sum of 2 quarters · filed 2026-03-04
$5.67M
derived: sum of 3 quarters · filed 2026-03-04
$7.43M
10-K · filed 2026-03-04
2024-09-30$1.89M
10-Q · filed 2025-11-05
$3.79M
derived: sum of 2 quarters · filed 2025-11-05
$5.55M
10-Q · filed 2025-11-05
$7.27M
derived: sum of 4 quarters · filed 2025-11-05
2024-06-30$1.90M
10-Q · filed 2025-08-04
$3.66M
10-Q · filed 2025-08-04
$5.38M
derived: sum of 3 quarters · filed 2025-08-04
$7.55M
derived: sum of 4 quarters · filed 2025-08-04
2024-03-31$1.76M
10-Q · filed 2025-05-09
$3.48M
derived: sum of 2 quarters · filed 2025-05-09
$5.66M
derived: sum of 3 quarters · filed 2025-05-09
$8.29M
derived: sum of 4 quarters · filed 2025-05-09
2023-12-31$1.72M
derived: 10-K 12 month − 10-Q 9 month · filed 2025-03-05
$3.90M
derived: sum of 2 quarters · filed 2025-03-05
$6.53M
derived: sum of 3 quarters · filed 2025-03-05
$9.22M
10-K · filed 2025-03-05
2023-09-30$2.17M
10-Q · filed 2024-11-14
$4.81M
derived: sum of 2 quarters · filed 2024-11-14
$7.50M
10-Q · filed 2024-11-14
$10.16M
derived: sum of 4 quarters · filed 2024-11-14
2023-06-30$2.63M
10-Q · filed 2024-08-08
$5.32M
10-Q · filed 2024-08-08
$7.99M
derived: sum of 3 quarters · filed 2024-08-08
$10.48M
derived: sum of 4 quarters · filed 2024-08-08
2023-03-31$2.69M
10-Q · filed 2024-05-14
$5.36M
derived: sum of 2 quarters · filed 2024-05-14
$7.85M
derived: sum of 3 quarters · filed 2024-05-14
$9.93M
derived: sum of 4 quarters · filed 2024-05-14
2022-12-31$2.67M
derived: 10-K 12 month − 10-K 9 month · filed 2024-04-16
$5.16M
derived: sum of 2 quarters · filed 2024-04-16
$7.24M
derived: sum of 3 quarters · filed 2024-04-16
$10.54M
10-K · filed 2024-04-16
2022-09-30$2.50M
10-Q · filed 2023-11-09
$4.57M
derived: sum of 2 quarters · filed 2023-11-09
$7.87M
10-K · filed 2024-04-16
$10.56M
derived: sum of 4 quarters · filed 2024-04-16
2022-06-30$2.08M
10-Q · filed 2023-08-21
$5.38M
10-K · filed 2024-04-16
$8.06M
derived: sum of 3 quarters · filed 2024-04-16
$9.41M
derived: sum of 4 quarters · filed 2024-04-16
2022-03-31$3.30M
10-K · filed 2024-04-16
$5.98M
derived: sum of 2 quarters · filed 2024-04-16
$7.33M
derived: sum of 3 quarters · filed 2024-04-16
$9.42M
derived: sum of 4 quarters · filed 2024-04-16
2021-12-31$2.68M
derived: 10-K 12 month − 10-Q 9 month · filed 2023-02-28
$4.03M
derived: sum of 2 quarters · filed 2023-02-28
$6.13M
derived: sum of 3 quarters · filed 2023-02-28
$6.96M
10-K · filed 2023-02-28
2021-09-30$1.35M
10-Q · filed 2022-11-08
$3.44M
derived: sum of 2 quarters · filed 2022-11-08
$4.28M
10-Q · filed 2022-11-08
$4.44M
derived: sum of 4 quarters · filed 2022-11-08
2021-06-30$2.10M
10-Q · filed 2022-08-05
$2.93M
10-Q · filed 2022-08-05
$3.09M
derived: sum of 3 quarters · filed 2022-08-05
$3.22M
derived: sum of 4 quarters · filed 2022-08-05
2021-03-31$833.00K
10-Q · filed 2022-05-06
$996.00K
derived: sum of 2 quarters · filed 2022-05-06
$1.12M
derived: sum of 3 quarters · filed 2022-05-06
$1.27M
derived: sum of 4 quarters · filed 2022-05-06
2020-12-31$163.00K
derived: 10-K 12 month − 10-Q 9 month · filed 2022-02-28
$289.00K
derived: sum of 2 quarters · filed 2022-02-28
$438.00K
derived: sum of 3 quarters · filed 2022-02-28
$660.00K
10-K · filed 2022-02-28
$660.32K
10-K · filed 2021-03-19
2020-09-30$126.00K
10-Q · filed 2021-11-09
$126.29K
10-Q · filed 2020-11-06
$275.00K
derived: sum of 2 quarters · filed 2021-11-09
$497.00K
10-Q · filed 2021-11-09
$498.01K
10-Q · filed 2020-11-06
$660.99K
derived: sum of 4 quarters · filed 2022-02-28
2020-06-30$149.00K
10-Q · filed 2021-08-06
$149.21K
10-Q · filed 2020-08-14
$371.00K
10-Q · filed 2021-08-06
$371.72K
10-Q · filed 2020-08-14
$534.99K
derived: sum of 3 quarters · filed 2022-02-28
$727.99K
derived: sum of 4 quarters · filed 2022-02-28
2020-03-31$222.00K
10-Q · filed 2021-05-07
$222.51K
10-Q · filed 2020-05-08
$385.99K
derived: sum of 2 quarters · filed 2022-02-28
$578.99K
derived: sum of 3 quarters · filed 2022-02-28
$690.80K
derived: sum of 4 quarters · filed 2022-02-28
2019-12-31$163.99K
derived: 10-K 12 month − 10-Q 9 month · filed 2022-02-28
$356.99K
derived: sum of 2 quarters · filed 2022-02-28
$468.80K
derived: sum of 3 quarters · filed 2022-02-28
$884.00K
10-K · filed 2022-02-28
$884.09K
10-K · filed 2020-03-27
2019-09-30$193.00K
10-Q · filed 2020-11-06
$304.81K
derived: sum of 2 quarters · filed 2020-11-06
$720.01K
10-Q · filed 2020-11-06
$1.05M
derived: sum of 4 quarters · filed 2020-11-06
2019-06-30$111.81K
10-Q · filed 2020-08-14
$36.00K
10-Q · filed 2019-08-09
$527.01K
10-Q · filed 2020-08-14
$144.00K
10-Q · filed 2019-08-09
$855.61K
derived: sum of 3 quarters · filed 2020-08-14
$1.29M
derived: sum of 4 quarters · filed 2020-08-14
2019-03-31$415.20K
10-Q · filed 2020-05-08
$107.00K
10-Q · filed 2019-05-15
$743.81K
derived: sum of 2 quarters · filed 2020-05-08
$1.18M
derived: sum of 3 quarters · filed 2020-05-08
$1.59M
derived: sum of 4 quarters · filed 2020-05-08
2018-12-31$328.60K
derived: 10-K 12 month − 10-Q 9 month · filed 2020-03-27
$766.60K
derived: sum of 2 quarters · filed 2020-03-27
$1.17M
derived: sum of 3 quarters · filed 2020-03-27
$1.07M
10-K · filed 2020-03-27
$1.63M
10-K · filed 2019-03-22
2018-09-30$438.00K
10-Q · filed 2018-11-08
$846.00K
derived: sum of 2 quarters · filed 2019-08-09
$746.08K
10-Q · filed 2019-11-12
$1.25M
10-Q · filed 2018-11-08
$1.59M
derived: sum of 4 quarters · filed 2019-08-09
2018-06-30$408.00K
10-Q · filed 2019-08-09
$519.87K
8-K/A · filed 2019-10-07
$810.00K
10-Q · filed 2018-08-09
$1.15M
derived: sum of 3 quarters · filed 2019-08-09
$1.52M
derived: sum of 4 quarters · filed 2019-08-09
2018-03-31$403.00K
10-Q · filed 2019-05-15
$743.00K
derived: sum of 2 quarters · filed 2019-05-15
$1.11M
derived: sum of 3 quarters · filed 2019-05-15
$1.48M
derived: sum of 4 quarters · filed 2019-05-15
2017-12-31$340.00K
derived: 10-K 12 month − 10-Q 9 month · filed 2019-03-22
$709.00K
derived: sum of 2 quarters · filed 2019-03-22
$1.08M
derived: sum of 3 quarters · filed 2019-03-22
$1.57M
10-K · filed 2019-03-22
2017-09-30$369.00K
10-Q · filed 2018-11-08
$740.00K
derived: sum of 2 quarters · filed 2018-11-08
$1.23M
10-Q · filed 2018-11-08
$1.70M
derived: sum of 4 quarters · filed 2018-11-08
2017-06-30$371.00K
10-Q · filed 2018-08-09
$864.00K
10-Q · filed 2018-08-09
$1.33M
derived: sum of 3 quarters · filed 2018-08-09
$1.77M
derived: sum of 4 quarters · filed 2018-08-09
2017-03-31$492.00K
10-Q · filed 2018-05-10
$960.00K
derived: sum of 2 quarters · filed 2018-05-10
$1.40M
derived: sum of 3 quarters · filed 2018-05-10
$1.73M
derived: sum of 4 quarters · filed 2018-05-10
2016-12-31$468.00K
derived: 10-K 12 month − 10-Q 9 month · filed 2018-03-15
$903.00K
derived: sum of 2 quarters · filed 2018-03-15
$1.24M
derived: sum of 3 quarters · filed 2018-03-15
$1.55M
10-K · filed 2018-03-15
2016-09-30$435.00K
10-Q · filed 2017-11-09
$771.00K
derived: sum of 2 quarters · filed 2017-11-09
$1.08M
10-Q · filed 2017-11-09
$1.46M
derived: sum of 4 quarters · filed 2017-11-09
2016-06-30$336.00K
10-Q · filed 2017-08-10
$647.00K
10-Q · filed 2017-08-10
$1.02M
derived: sum of 3 quarters · filed 2017-08-10
$1.38M
derived: sum of 4 quarters · filed 2017-08-10
2016-03-31$311.00K
10-Q · filed 2017-05-11
$685.00K
derived: sum of 2 quarters · filed 2017-05-11
$1.05M
derived: sum of 3 quarters · filed 2017-05-11
$1.30M
derived: sum of 4 quarters · filed 2017-05-11
2015-12-31$374.00K
derived: 10-K 12 month − 10-Q 9 month · filed 2017-03-16
$736.00K
derived: sum of 2 quarters · filed 2017-03-16
$993.00K
derived: sum of 3 quarters · filed 2017-03-16
$1.23M
10-K · filed 2017-03-16
2015-09-30$362.00K
10-Q · filed 2016-11-10
$619.00K
derived: sum of 2 quarters · filed 2016-11-10
$854.00K
10-Q · filed 2016-11-10
$1.04M
derived: sum of 4 quarters · filed 2016-11-10
2015-06-30$257.00K
10-Q · filed 2016-08-11
$492.00K
10-Q · filed 2016-08-11
$683.00K
derived: sum of 3 quarters · filed 2016-08-11
$851.00K
derived: sum of 4 quarters · filed 2016-08-11
2015-03-31$235.00K
10-Q · filed 2016-05-12
$426.00K
derived: sum of 2 quarters · filed 2016-05-12
$594.00K
derived: sum of 3 quarters · filed 2016-05-12
$706.00K
derived: sum of 4 quarters · filed 2016-05-12
2014-12-31$191.00K
derived: 10-K 12 month − 10-Q 9 month · filed 2016-03-10
$359.00K
derived: sum of 2 quarters · filed 2016-03-10
$471.00K
derived: sum of 3 quarters · filed 2016-03-10
$547.00K
10-K · filed 2016-03-10
2014-09-30$168.00K
10-Q · filed 2015-11-12
$280.00K
derived: sum of 2 quarters · filed 2015-11-12
$356.00K
10-Q · filed 2015-11-12
2014-06-30$112.00K
10-Q · filed 2015-08-12
$188.00K
10-Q · filed 2015-08-12
2014-03-31$76.00K
10-Q · filed 2015-05-14

Similar stocks

Stock NameCountryMarket CapPE Ratio
Cabaletta Bio, Inc. (CABA)United States$0.365B-2.81
Artiva Biotherapeutics, Inc. (ARTV)United States$0.367B
FENNEC PHARMACEUTICALS INC. (FENC)United States$0.371B-115.85
C4 Therapeutics, Inc. (CCCC)United States$0.373B-5.65
Century Therapeutics, Inc. (IPSC)United States$0.306B-4.02
SAB Biotherapeutics, Inc. (SABS)United States$0.306B-25.49
AGENUS INC (AGEN)United States$0.383B1.41
X4 Pharmaceuticals, Inc (XFOR)United States$0.297B-4.99
Inhibikase Therapeutics, Inc. (IKT)United States$0.296B-4.44
Surrozen, Inc./DE (SRZN)United States$0.395B